SonoThera Launches $125M Series B. Learn more here.
Category

Press Release

SonoThera logo
Press Release,

SonoThera to Present at ASN Kidney Week 2024 Demonstrating the Potential of Novel Nonviral Ultrasound-Mediated Gene Therapy Delivery Platform

South San Francisco, CA, October 22, 2024 – SonoThera™, a biotechnology company dedicated to treating the...
October 22, 2024
By dev_team
SonoThera logo
Press Release,

SonoThera™ to Present Late Breakthrough Data at ISTH 2024 on Development of Nonviral Hemophilia A Gene Therapy Treatment

South San Francisco, CA, June 23, 2024 – SonoThera™, a biotechnology company dedicated to treating the...
June 23, 2024
By dev_team
SonoThera logo
Press Release,

SonoThera™ to Present Four Abstracts at the 2024 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

South San Francisco, CA, April 30, 2024 – SonoThera™, a biotechnology company dedicated to treating the...
April 30, 2024
By dev_team
SonoThera logo
Press Release,

SonoThera™ Expands Leadership Team Appointing Carolyne Zimmermann as Chief Business Officer

South San Francisco, CA, June 27, 2022 – SonoThera™, a biotechnology company dedicated to treating the...
June 27, 2023
By dev_team
SonoThera logo
Press Release,

SonoThera™ Announces Research Collaboration with Janssen Pharmaceuticals, Inc. to Accelerate Development of Ultrasound-Guided Nonviral Gene Therapy Platform

South San Francisco, CA, May 15, 2023 – SonoThera™, a biotechnology company dedicated to treating the...
May 15, 2023
By dev_team
SonoThera logo
Press Release,

SonoThera™ to Present Preclinical Data on Use of Its Ultrasound-Guided Gene Therapy Platform at the 2023 ASGCT Annual Meeting

May 11, 2023
By dev_team
SonoThera logo
Press Release,

SonoThera™ Receives Exclusive Licensing of GE HealthCare’s Optison® and Sonazoid® Microbubble Products for use with its Ultrasound-guided Gene Therapy Platform

February 27, 2023
By dev_team
SonoThera logo
Press Release,

SonoThera™ Completes $60.75M Series A Funding for Ultrasound-Guided, Nonviral Gene Therapy Platform Development

South San Francisco, CA, December 5, 2022 – SonoThera™, a biotechnology company dedicated to treating the...
December 5, 2022
By dev_team

Inquiries about our Clinical Research

Contact Us